Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Non-Current Assets came in at $152.3 million in Q2 2026, up 3.25% year-over-year from $147.5 million in Q2 2025, and little changed quarter-over-quarter from $151.7 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Non-Current Assets for 17 consecutive years, with $152.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 3.25% year-over-year to $152.3 million in Q2 2026; TTM through Jun 2026 was $597.5 million, a 0.43% change from a year earlier, with the FY2025 full-year figure at $147.5 million, down 1.45% from the prior year.
  • Non-Current Assets was $152.3 million for Q2 2026 at Lemaitre Vascular, roughly flat from $151.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $152.3 million in Q2 2026 and troughed at $146.0 million in Q3 2025.
  • A 5-year average of $150.0 million and a median of $150.2 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets dropped 4.21% in 2022 and increased 3.25% in 2026, its largest moves.
  • Over 5 years, Non-Current Assets stood at $148.7 million in 2022, then rose by 2.31% to $152.2 million in 2023, then slipped by 1.68% to $149.6 million in 2024, then declined by 1.45% to $147.5 million in 2025, then increased by 3.25% to $152.3 million in 2026.
  • The last three Non-Current Assets figures came in at $152.3 million (Q2 2026), $151.7 million (Q1 2026), and $147.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 68.92 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 7.05 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 2.37 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 8.29 Bn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 152.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152.25 Mn
Mar 31, 2026 151.71 Mn
Dec 31, 2025 147.46 Mn
Sep 30, 2025 146.04 Mn
Jun 30, 2025 147.47 Mn
Mar 31, 2025 147.89 Mn
Dec 31, 2024 149.63 Mn
Sep 30, 2024 149.91 Mn
Jun 30, 2024 150.27 Mn
Mar 31, 2024 151.00 Mn
Dec 31, 2023 152.18 Mn
Sep 30, 2023 151.83 Mn
Jun 30, 2023 151.98 Mn
Mar 31, 2023 150.10 Mn
Dec 31, 2022 148.74 Mn
Sep 30, 2022 148.91 Mn
Jun 30, 2022 150.94 Mn
Mar 31, 2022 151.04 Mn
Dec 31, 2021 152.92 Mn
Sep 30, 2021 155.46 Mn